文献速递瓣膜外科

2009至2015年主动脉瓣置换术趋势:经导管主动脉瓣置换术是否带来了改变

Trends in Aortic Valve Replacement Procedures Between 2009 and 2015: Has Transcatheter Aortic Valve Replacement Made a Difference?
PubMed 文献 · Ann Thorac Surg · 2018-02-01

该回顾性研究利用美国联邦医疗保险(Medicare)年度财政数据,分析2009至2015年接受孤立主动脉瓣手术的233,660例住院病例。期间手术量从22,076例增至49,362例,年均增长14.45%;经导管主动脉瓣置换术(TAVR)每10万受益人从2012年10.7例增至2015年41.1例,住院死亡率、30天累积死亡率和出院后90天死亡率逐年下降,但TAVR的90天死亡率接近组织型外科主动脉瓣置换组的兩倍。

要点

  • 2009至2015年孤立主动脉瓣手术量从每10万受益人47.5例增至88.9例,年均增长14.45%。
  • TAVR每10万受益人从2012年10.7例增至2015年41.1例,是手术量增长的主要原因。
  • TAVR的90天死亡率接近组织型外科主动脉瓣置换组的兩倍,但2015年TAVR的院内不良事件率最低。

核心结论

  • 研究期间接受孤立主动脉瓣手术的Medicare受益人总数从每10万受益人47.5例增至88.9例。
  • 主动脉瓣手术量显著增加,主要归因于TAVR的增加,临床结局也有所改善。
  • TAVR的长期结局仍在研究中,但上述结果令人鼓舞。

研究设计与样本

  • 回顾性研究,使用年度财政年Medicare提供者分析与审查文件识别所有接受孤立主动脉瓣手术的Medicare受益人。
  • 最终研究人群包括233,660例住院病例。
  • 结局指标包括三种死亡率和九种院内不良事件。

主要发现

  • 接受主动脉瓣手术的Medicare受益人从22,076例增至49,362例,年均增长率为14.45%。
  • TAVR每10万Medicare受益人从2012年的10.7例增至2015年的41.1例。
  • 研究期间,院内死亡率、累积30天死亡率和出院后90天死亡率逐年下降。
  • TAVR的90天死亡率接近组织型外科主动脉瓣置换组的兩倍。
  • 近68%的Medicare受益人在索引住院期间经历至少一次院内不良事件;2015年TAVR的观察不良事件率在主动脉瓣手术中最低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study reports trends in volume and adverse events associated with isolated aortic valve procedures performed in Medicare beneficiaries between 2009 and 2015. METHODS: This retrospective study used the annual fiscal year Medicare Provider Analysis and Review file to identify all Medicare beneficiaries undergoing an isolated aortic valve procedure. Outcome measures included three mortality rates and nine in-hospital adverse events. The final study population consisted of 233,660 hospitalizations. RESULTS: During the study period, Medicare beneficiaries undergoing an aortic valve procedure increased from 22,076 to 49,362, for an average annual growth rate of 14.45%. Transcatheter aortic valve replacement (TAVR) procedures per 100,000 Medicare beneficiaries grew from 10.7 in 2012 to 41.1 in 2015. Overall, in-hospital mortality rates, cumulative 30-day mortality rates, and 90-day postdischarge mortality rates declined annually during the study period. However, the 90-day mortality rate for TAVR was nearly double the rate for the tissue surgical aortic valve replacement group. Nearly 68% of Medicare beneficiaries experienced at least one in-hospital adverse event during their index hospitalization. Medicare beneficiaries undergoing TAVR had the lowest observed adverse events rates among the aortic valve procedures in 2015. CONCLUSIONS: The total number of Medicare beneficiaries undergoing isolated aortic valve procedures increased from 47.5 to 88.9 per 100,000 Medicare beneficiaries during the study period. Aortic valve procedures increased significantly during this study period primarily due to the increase in TAVR, with clinical outcomes improving as well. Although long-term outcomes of TAVR are still under investigation, these results are promising.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Culler SD, Cohen DJ, Brown PP, et al. Trends in Aortic Valve Replacement Procedures Between 2009 and 2015: Has Transcatheter Aortic Valve Replacement Made a Difference? Ann Thorac Surg. 2018. PMID: 29394992. doi:10.1016/j.athoracsur.2017.10.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。